MARK4 and Alzheimer disease: Knocking down MARK4 or reducing hyperphosporylated tau via DEPTAC in P301L mice significantly ameliorated AD-like tau pathology in dvCA1Calb1− neurons and improved temporal-order discrimination of objects.